MedTrace Logo

The Impact of Oral Health in HIV Patients on Antiretroviral Therapy

NCT04645693 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 227

Last updated 2026-05-05

No results posted yet for this study

Summary

This is a prospective cohort study designed to investigate the range of metabolic abnormalities observed in patients living with HIV on antiretroviral therapy. This study will also explore the concurrent role of poor oral health in supporting and driving chronic immune activation and inflammation in HIV infection.

Conditions

  • HIV
  • Periodontal Diseases
  • Caries
  • Non-communicable Disease
  • Xerostomia

Sponsors & Collaborators

Principal Investigators

  • Temitope Omolehinwa, BDS, DScD · University of Pennsylvania

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-24
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645693 on ClinicalTrials.gov